First experience with therapy of severe forms of psoriasis with biosimilar infliximab
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F16%3A33158459" target="_blank" >RIV/61989592:15110/16:33158459 - isvavai.cz</a>
Result on the web
<a href="http://onlinelibrary.wiley.com/doi/10.1111/jdv.12876/epdf" target="_blank" >http://onlinelibrary.wiley.com/doi/10.1111/jdv.12876/epdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/jdv.12876" target="_blank" >10.1111/jdv.12876</a>
Alternative languages
Result language
angličtina
Original language name
First experience with therapy of severe forms of psoriasis with biosimilar infliximab
Original language description
Biosimilar infliximab is the first biologically similar medicine to be directly used in dermatological practice. Since the efficacy and safety of the product was only established in patients with rheumatoid arthritis and ankylosing spondylarthritis, no clinical data in other indications are available. In the European Union in dermatology, based on the approval of the European Medicines Agency concerning data extrapolation to the other indications of the original infliximab, biosimilar infliximab may also be used for the treatment of severe forms of psoriasis. This report brings our first experience with the therapy of psoriasis using biosimilar infliximab in four patients.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FO - Dermatology and venereology
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of the European Academy of Dermatology and Venerology
ISSN
0926-9959
e-ISSN
—
Volume of the periodical
30
Issue of the periodical within the volume
3
Country of publishing house
GB - UNITED KINGDOM
Number of pages
3
Pages from-to
491-493
UT code for WoS article
000371262200036
EID of the result in the Scopus database
—